Goa Health Department Implements "Code Red" Protocol After Temple Stampede
In the aftermath of the tragic death of six devotees in a stampede, the Goa health department has announced the phase-wise implementation of a "code red" system in hospitals to ensure swift response to emergencies.
State Health Minister Vishwajit Rane said on Sunday that the code red protocol will be implemented in the Goa Medical College and Hospital (GMCH) and later in district hospitals and the Super Speciality Hospital.
After visiting the injured devotees at GMCH, Mr Rane said two to three patients are in critical condition. While two among them have responded positively to treatment, close monitoring is needed.
Six devotees were killed and about 70 injured in a stampede that occurred in the early hours of Saturday during the annual Sree Lairai Devi temple festival in Shirgao village in north Goa.
Mr Rane said "code red" is an internationally-established emergency response protocol.
"Code Red protocol activates automatically during medical emergencies in hospitals. You don't need to wait for any department or individual to respond. Under this system, multi-disciplinary doctors are immediately engaged to ensure quick and necessary decisions," he said.
The health minister further said the system will be implemented in three phases starting with GMCH.
He exuded confidence in the code red mechanism to deal with emergencies more effectively.
Mr Rane said he visited the injured devotees and discussed the treatment protocols with treating doctors.
"I told doctors that the government will immediately act on any demand for engaging specialists from any part of the country to treat the injured persons or backup systems needed to stabilise patients," he added.
(Except for the headline, this story has not been edited by NDTV staff and is published from a syndicated feed.)
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
News18
a day ago
- News18
Goa launches policy to make lifesaving therapies more affordable, accessible
Agency: PTI Panaji, Aug 14 (PTI) The Goa government on Thursday launched a pricing policy to make lifesaving therapies more affordable and accessible, state health minister Vishwajit Rane said on Thursday. Under the policy, the state government will negotiate lower drug and equipment prices with pharmaceutical companies to benefit citizens with rare genetic disorders, cancer and autoimmune diseases, said officials. 'Today marks a landmark moment for healthcare in Goa with the launch of Goa's Pricing Policy for Innovative Lifesaving Therapies, which is a first in India," Rane told reporters after launching the policy in Panaji. He said this 'pioneering" policy ensures fair and sustainable pricing for critical treatments, the minister said. 'It will make life-saving therapies far more affordable and accessible, giving new hope to patients and families across the state," the minister said. The initiative will reduce the financial burden on patients, improve access to cutting-edge treatments and set a national benchmark for equitable healthcare, said Rane. 'This is not just a policy. It's a promise of better health and a brighter future for all," the minister added. A senior health department official said that under the policy, the state will procure drugs, medical equipment and diagnostics from pharma companies at a lower negotiated rate, enabling fair allocation of budget among more patients or supporting a longer duration for therapies. He said a committee chaired by the Additional Secretary or Joint Secretary of the Goa government and comprising the Dean of Goa Medical College and the State Director of Health Services has been constituted to recommend appropriate pricing for government approval. PTI RPS NR (This story has not been edited by News18 staff and is published from a syndicated news agency feed - PTI) view comments First Published: August 14, 2025, 16:30 IST Disclaimer: Comments reflect users' views, not News18's. Please keep discussions respectful and constructive. Abusive, defamatory, or illegal comments will be removed. News18 may disable any comment at its discretion. By posting, you agree to our Terms of Use and Privacy Policy.
Economic Times
a day ago
- Economic Times
Goa becomes India's first state to cut prices on high-cost cancer and rare disease therapies
Synopsis Goa government introduces a pioneering pricing policy for expensive treatments, including cancer and rare diseases, making it the first state in India to do so. This initiative allows the state to negotiate prices for drugs, medical equipment, and diagnostics, ensuring more patients can access critical care. ETHealthWorld In a bid to make life-saving therapies more accessible to patients, the Goa government has introduced a groundbreaking pricing policy for expensive treatments, including those for cancer and rare diseases, according to a TOI report. The initiative allows the state to procure drugs, medical equipment, and diagnostics at negotiated prices below the listed rates, enabling resources to reach a larger number of patients or extend the duration of therapies. Health Minister Vishwajit Rane announced on Wednesday that Goa is the first state in the country to implement such a policy framework, which facilitates confidential pricing agreements with pharmaceutical companies and medical device manufacturers. The rollout is expected to begin with treatments for lung cancer, a condition among several high-cost therapies that can exceed Rs 50 lakh per year. According to Rane, this initiative represents a significant step toward health equity, ensuring more patients can access critical care. 'Goa's adoption of this value-based pricing policy is both timely and essential,' Rane said. 'It will improve access to innovative therapies and help more patients benefit from these treatments.' Addressing the rising burden of diseases The report noted that Goa faces a growing healthcare challenge, with around 1,500 new cancer cases diagnosed annually, expected to rise by 5% each year. Breast cancer is the most common, accounting for over 300 cases, followed by oral cavity cancer, which makes up 20-25% of total cases. Rane highlighted the need for a more robust healthcare system to meet the increasing demand for specialized treatments and rare disease management. Policy framework & implementation The new pricing policy focuses on proprietary drugs and equipment already procured by the Goa Medical College (GMC) and the Directorate of Health Services (DHS) through standard tenders. If new patented drugs or devices are required, a committee will review the recommendation and seek approval from the finance department before inclusion. A committee led by the Additional/Joint Secretary of Health, along with the GMC dean, DHS director, and pharmacy heads, will determine appropriate pricing and negotiate with companies to secure the best rates for patented treatments. Once approved, the finalized list of drugs and equipment will be notified with finance department approval, TOI further reported. This move is expected to ease financial pressure on patients while equipping Goa's healthcare system to better handle the rising incidence of cancer and rare disorders, setting a precedent for other states to follow.
Time of India
a day ago
- Time of India
Goa becomes India's first state to cut prices on high-cost cancer and rare disease therapies
In a bid to make life-saving therapies more accessible to patients, the Goa government has introduced a groundbreaking pricing policy for expensive treatments, including those for cancer and rare diseases, according to a TOI report. Independence Day 2025 Before Trump, British used tariffs to kill Indian textile Bank of Azad Hind: When Netaji gave India its own currency Swadeshi 2.0: India is no longer just a market, it's a maker The initiative allows the state to procure drugs, medical equipment, and diagnostics at negotiated prices below the listed rates, enabling resources to reach a larger number of patients or extend the duration of therapies. Health Minister Vishwajit Rane announced on Wednesday that Goa is the first state in the country to implement such a policy framework, which facilitates confidential pricing agreements with pharmaceutical companies and medical device manufacturers. The rollout is expected to begin with treatments for lung cancer, a condition among several high-cost therapies that can exceed Rs 50 lakh per year. According to Rane, this initiative represents a significant step toward health equity, ensuring more patients can access critical care. 'Goa's adoption of this value-based pricing policy is both timely and essential,' Rane said. 'It will improve access to innovative therapies and help more patients benefit from these treatments.' Live Events Addressing the rising burden of diseases The report noted that Goa faces a growing healthcare challenge, with around 1,500 new cancer cases diagnosed annually, expected to rise by 5% each year. Breast cancer is the most common, accounting for over 300 cases, followed by oral cavity cancer, which makes up 20-25% of total cases. Rane highlighted the need for a more robust healthcare system to meet the increasing demand for specialized treatments and rare disease management. Policy framework & implementation The new pricing policy focuses on proprietary drugs and equipment already procured by the Goa Medical College (GMC) and the Directorate of Health Services (DHS) through standard tenders. If new patented drugs or devices are required, a committee will review the recommendation and seek approval from the finance department before inclusion. A committee led by the Additional/Joint Secretary of Health, along with the GMC dean, DHS director, and pharmacy heads, will determine appropriate pricing and negotiate with companies to secure the best rates for patented treatments. Once approved, the finalized list of drugs and equipment will be notified with finance department approval, TOI further reported. This move is expected to ease financial pressure on patients while equipping Goa's healthcare system to better handle the rising incidence of cancer and rare disorders, setting a precedent for other states to follow.
